Etodolac Capsule Etodolac

Etodolac Capsule Etodolac

Etodolac Capsule Etodolac Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

1.1. Hypertension

Amlodipine besylate tablets, USP are indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.

1.2. Coronary Artery Disease (CAD)

Chronic Stable Angina

Amlodipine besylate tablets, USP are indicated for the symptomatic treatment of chronic stable angina. Amlodipine besylate tablets, USP may be used alone or in combination with other antianginal agents.

Vasospastic Angina (Prinzmetal’s or Variant Angina)

Amlodipine besylate tablets, USP are indicated for the treatment of confirmed or suspected vasospastic angina. Amlodipine besylate tablets, USP may be used as monotherapy or in combination with other antianginal agents.

Angiographically Documented CAD

In patients with recently documented CAD by angiography and without heart failure or an ejection fraction <40%, amlodipine besylate tablets, USP are indicated to reduce the risk of hospitalization due to angina and to reduce the risk of a coronary revascularization procedure.

History

There is currently no drug history available for this drug.

Other Information

Amlodipine besylate, USP is the besylate salt of amlodipine, a long-acting calcium channel blocker.

Amlodipine besylate, USP is chemically described as 3-Ethyl-5-methyl (±)-2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate, monobenzenesulphonate. Its empirical formula is C20H25CIN2O5 • C6H6O3S, and its structural formula is:

8352ab43-figure-01

Amlodipine besylate, USP is a white crystalline powder with a molecular weight of 567.1. It is slightly soluble in water and sparingly soluble in ethanol. Amlodipine besylate tablets, USP are formulated as white tablets equivalent to 2.5 mg, 5 mg, and 10 mg of amlodipine for oral administration. In addition to the active ingredient, amlodipine besylate, USP each tablet contains the following inactive ingredients: microcrystalline cellulose, dibasic calcium phosphate anhydrous, sodium starch glycolate, and magnesium stearate.

Etodolac Capsule Etodolac Manufacturers


  • Kaiser Foundation Hospitals
    Etodolac Capsule Etodolac Tablet, Film Coated [Kaiser Foundation Hospitals]
  • Taro Pharmaceuticals Laboratories, Inc.
    Etodolac Capsule Etodolac Tablet [Taro Pharmaceuticals Laboratories, Inc.]
  • Physicians Total Care, Inc.
    Etodolac Capsule Etodolac Tablet, Film Coated [Physicians Total Care, Inc.]
  • Golden State Medical Supply, Inc.
    Etodolac Capsule Etodolac Tablet, Film Coated Etodolac Tablet, Film Coated, Extended Release [Golden State Medical Supply, Inc.]
  • Taro Pharmaceuticals U.s.a., Inc.
    Etodolac Capsule Etodolac Tablet, Film Coated [Taro Pharmaceuticals U.s.a., Inc.]
  • Stat Rx Usa Llc
    Etodolac Capsule Etodolac Tablet [Stat Rx Usa Llc]
  • Preferred Pharmaceuticals, Inc
    Etodolac Capsule Etodolac Tablet, Film Coated [Preferred Pharmaceuticals, Inc]
  • Aphena Pharma Solutions – Tennessee, Llc
    Etodolac Capsule Etodolac Tablet, Film Coated [Aphena Pharma Solutions – Tennessee, Llc]

Login To Your Free Account